Viewing Study NCT02726867

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-24 @ 8:51 PM
Study NCT ID: NCT02726867
Status: WITHDRAWN
Last Update Posted: 2017-08-29
First Post: 2014-12-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
None Status Epilepticus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory status epilepticus View
None levetiracetam View
None lacosamide View
None ketamine View